Navigation Links
Discovery of new hormone opens doors to new type 2 diabetes treatments
Date:5/7/2013

d insulin production in the pancreas, resulting in too much glucose in the blood.

The majority of cases of type 2 diabetes are related to failure of insulin action in the body. However, for decades researchers and physicians have been faced with a conundrum: not all who are obese or resistant to insulin develop type 2 diabetes. In fact, many patients who are severely obese never develop the disease. As a result scientists have theorized that an unknown factor is involved in regulating glucose metabolism in the liver, and perhaps the presence or absence of this element might determine who gets the disease.

"It was surprising to find that a critical hormone playing a pathological role in diabetes turned out to be the secreted form of aP2, which for decades has been considered a protein that resides inside the fat cells," said Hotamisligil. In the new study, HSPH researchers first increased the levels of aP2 in normal, healthy mice to match the high blood aP2 levels seen in obese mice and humans. This resulted in impaired glucose metabolism. Next, they reduced the blood aP2 levels in obese and diabetic mice to low levels seen in lean healthy mice. This intervention restored glucose metabolism to its normal status. Therefore, the investigators reached the conclusion that the amount and action of aP2 in blood was critical for diabetes, opening up new avenues for potentially being able control or prevent type 2 diabetes. The researchers also identified a potential therapeutic role for a novel aP2 antibody that neutralizes aP2 activity and corrects type 2 diabetes in mice.

"The consequences of this discovery are profound, and the potential therapeutic applications by switching this protein off have the capability to reshape the way physicians treat diabetes," said lead author Haiming Cao, postdoctoral fellow in the Department of Genetics and Complex Diseases at HSPH.


'/>"/>

Contact: Marge Dwyer
mhdwyer@hsph.harvard.edu
617-432-8416
Harvard School of Public Health
Source:Eurekalert

Page: 1 2

Related biology news :

1. Discovery may help prevent chemotherapy-induced anemia
2. Discovery may help prevent HIV reservoirs from forming
3. An important discovery in breast cancer by IRCM researchers
4. Genetic discovery found to influence obesity in people of African ancestry
5. Accidental discovery may lead to improved polymers
6. Gene discovery may yield lettuce that will sprout in hot weather
7. UGA discovery may allow scientists to make fuel from CO2 in the atmosphere
8. Discovery could increase efficacy of promising cystic fibrosis drug
9. Discovery of first motor with revolution motion in a virus-killing bacteria advances nanotechnology
10. Discovery could yield treatment for cocaine addicts
11. Discovery may explain how prion diseases spread between different types of animals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2015)... 24, 2015   Crossmatch ™, a leading ... that its U.are.U ® 4500 Fingerprint Readers ... Bros . to achieve PCI compliance for Point-of-Sale ... to the POS terminal, protecting the retailer and ... breaches. With one-third of worldwide ...
(Date:3/23/2015)... , March 23, 2015   HOYOS Labs ... management company, today announced that the Company will demonstrate ... both enterprise and consumers at Connect:ID on March 23 ... HOYOS Labs will highlight the IEEE Biometric Open ... ; and enterprise access control system. BOPS was ...
(Date:3/23/2015)... , Mar. 23, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... on the growing mobile commerce market, announces its biometric payment ... campaign on CNBC television starting March 30 th . ... airing in New York markets. ... "We are excited about our new ad campaign following the ...
Breaking Biology News(10 mins):Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3
... TEMPE, Ariz. Research conducted in a computerized ... University, including Nobel laureate Elinor Ostrom, show how common-pool ... even bandwidth can be managed effectively by self-organized ... published April 30 in the journal Science . ...
... Protection Agency (EPA) is making it easier to find ... ToxRefDB, which allows scientists and the interested public to ... hundreds of chemicals. ToxRefDB captures 30 years and $2 ... chemicals are in commerce and current chemical testing is ...
... Williams of Baltimore was hired by Carnegie,s Department of Embryology ... program for inner city youth. Now as head technician and ... two degrees from Johns Hopkins University under her belt, she ... has been acknowledged for technical assistance on countless others. Genetics ...
Cached Biology News:Communication trumps penalties in new study of social-ecological systems 2Communication trumps penalties in new study of social-ecological systems 3US Environmental Protection Agency opens access to chemical information 2From lab dishwasher to distinguished researcher 2From lab dishwasher to distinguished researcher 3
(Date:4/30/2015)... May 01, 2015 Spirax Sarco, the ... extremely proud to announce that for the first time ... a winner of a Queen’s Award for Innovation – ... design and manufacture of a unique flowmeter. , The ... alternative to traditional steam flow measurement. The device ...
(Date:4/30/2015)... SAN DIEGO , April 30, 2015   ... drugs, announced today an update on its Ebola antiviral ... of Tamir,s leading candidates, TMR004, is currently being evaluated ... frontline of the battle against Ebola. During the first ... Voice And Leadership Meeting To Accelerate The Evaluation of ...
(Date:4/30/2015)... , April 30, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: ... chemicals, today announced that it has commenced an underwritten public ... to grant the underwriters a 30-day option to purchase ... of common stock offered in the public offering. The ... be no assurance as to whether or when the ...
(Date:4/30/2015)... , April 30, 2015 Oxford Finance ... debt to life sciences and healthcare services companies, today ... term loan agreement with Celula, Inc., a diagnostic testing ... diseases, enabling better patient care and improved outcomes.  Proceeds ... development and expand the commercialization of its products in ...
Breaking Biology Technology:Spirax Sarco Receives a Queen’s Award for Innovation 2Spirax Sarco Receives a Queen’s Award for Innovation 3Tamir Biotechnology Provides Update on TMR004 Development Against Mutating Ebola 2Tamir Biotechnology Provides Update on TMR004 Development Against Mutating Ebola 3Tamir Biotechnology Provides Update on TMR004 Development Against Mutating Ebola 4BioAmber Inc. Announces Public Offering Of Common Stock 2BioAmber Inc. Announces Public Offering Of Common Stock 3Oxford Finance Provides $10 Million Debt Financing to Celula 2
... Sept. 21 Emissary Capital Group, Inc. has initiated ... SNBP) with a Buy rating and target price of ... Ying Pharmaceutical Co. Ltd., is a fully integrated and ... distribution of biopharmaceutical products. The company focuses primarily ...
... , , ... Bulletin Board: GOVX) (the "Company"), an Atlanta-based, biopharmaceutical company developing ... and other infectious agents, today announced that it has requested ... and Drug Administration (FDA) to discuss a proposed IND for ...
... BETHESDA, Md., Sept. 21 Micromet, Inc. (Nasdaq: ... antibodies for the treatment of cancer, inflammation and autoimmune diseases, ... clinical study for BiTE antibody MT110, the first T-cell engaging ... were presented at the Multidisciplinary Congress of the European ...
Cached Biology Technology:Emissary Capital Group Initiates Coverage on Sinobiopharma 2GeoVax Labs Requests pre-IND Meeting With FDA 2GeoVax Labs Requests pre-IND Meeting With FDA 3Micromet Reports Interim Data from Phase 1 Study of BiTE Antibody MT110 for the Treatment of Solid Tumors 2Micromet Reports Interim Data from Phase 1 Study of BiTE Antibody MT110 for the Treatment of Solid Tumors 3Micromet Reports Interim Data from Phase 1 Study of BiTE Antibody MT110 for the Treatment of Solid Tumors 4
mu Opioid Receptor splice variant Immunogen: Synthetic peptide corresponding to residues K S C M D R G M R N L L P D D G P R Q E of Mu Opioid Receptor. Storage: -20 C, Avoid Freeze/Thaw Cycle...
Anti-Salmonid Ig (H), Alk Phos, (Clone IPA5F12) (mouse IgG2a)...
Rat monoclonal [HK5.3] to B7 RP1 (Phycoerythrin) ( Abpromise for all tested applications). entrezGeneID: 23308 SwissProtID: O75144...
... with the HECT protein, E6-AP ... Evidence suggests that this E2 ... degradation of non-""N-end rule"" protein ... -acetylated proteins as well as ...
Biology Products: